- Home
- SLS vs TKNO Comparison
SLS vs TKNO Comparison
Compare SLS & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | TKNO |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 236.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SLS | TKNO |
|---|---|---|
| Price | $1.54 | $4.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 174.0K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,801,000.00 |
| Revenue This Year | N/A | $9.52 |
| Revenue Next Year | N/A | $15.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $0.77 | $3.94 |
| 52 Week High | $2.48 | $10.37 |
Technical Indicators
Market Signals| Indicator | SLS | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 50.55 |
| Support Level | $1.39 | $4.41 |
| Resistance Level | $1.64 | $4.81 |
| Average True Range (ATR) | 0.12 | 0.29 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 57.69 | 92.42 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.